We are R&D partner for leading innovators in food and industrial markets.

Who we are

We are the link between academia and industry. With a highly integrated R&D approach – of fermentation technology and molecular biology – our company employs a large number of PhDs and university trained technicians. With this we offer our partners access to the forefront of fungal biotechnology.

Why we do it…

We aim to contribute to society by developing sustainable production processes for innovative products.

Our focus

Fungal fermentation is known for the highest production levels as compared to fermentation with yeast and bacteria. Just imagine the large scale on which citric acid, antibiotics and block buster enzymes are produced. Only fungi make it scalable and affordable. This is the reason for our focus on fungal biotechnology. We developed a platformtechnology that allows the discovery and production of enzymes and metabolites at high purity and low production costs.

How we do it…

Our R&D is based on solid project plans in which activities, budget and timelines with distinct milestones are described in relevant detail. After successful completion of the project we assist the partner to implement the technology in its own production facility or that of its Contract Manufacturing Organization. Learn more…

Our Idea…

Industrial Biotechnology is a highly innovative and competitive field. We should continuously reinvent our expertise. That, combined with the right partnerships, enables us to stay ahead in competition.

Partners should have complementary assets, strategic alignment and cultural fit

This manifests itself at Dutch DNA Biotech in having partners in both industry and at relevant and leading academic centers. The industrial partners range from listed corporate companies, to family businesses with global footprint and start-ups with a clear focus.

We are part of…

Together with Fungi Factory Biotech, we are part of Have Fungi Ventures. Within the group we – Dutch DNA Biotech – focus on the continuous improvement of the platformtechnology. If you want learn more about groupstrategy please contact Art de Boo, CEO of Have Fungi Ventures.

Management Team

Prof. Peter Punt

CSO

Peter, our Chief Scientific Officer, is world leading expert in the field of fungal molecular biology.

Dr Machtelt Braaksma

COO

Machtelt, our Chief Operating Officer, has broad experience in building and leading R&D teams within the Netherlands Organization for Applied Scientific Research TNO.

Dr Wim Van der Wilden

CEO

Wim, our Chief Executive Officer, is veteran in the business, having held managerial positions at amongst others Gist-Brocades (DSM), TNO, Kluyver Center and Dyadic.

Supervisory Board

Elmer Bol

Elmer is serial entrepreneur. He successfully founded and sold different high tech start-ups. Next to his executive roll in the Artificial Intelligence company All Vision, Elmer is advisor of several scale-up companies.

Art de Boo

Founder DDNA

Dr Willem Rensink

Willem started his carrier at Craig Venter Institute. Ever since he built carrier denominated by innovation. With experience in business development for large corporations like Shell and Novozymes he is well equipped to guide DDNA in building strategic partnerships to commercialize its proprietary product portfolio.